Search results
Earnings call: Regeneron reports steady growth, prepares for new launches By Investing.com
Investing.com· 1 hour agoThis growth was primarily driven by strong sales of Dupixent and Libtayo, as well as collaboration...
Regeneron Reverses On Better-Than-Feared Eylea Sales As Patent Expiration Looms
Investor's Business Daily· 4 hours agoRegeneron stock is forming a flat base with a buy point at 998.33, according to MarketSurge. That's...
AMGEN HIGHLIGHTS NEW COPD, ASTHMA AND VASCULITIS RESEARCH AT ATS 2024
WFRV 5 Green Bay· 2 days agoAmgen (NASDAQ:AMGN) today announced the presentation of new respiratory data at the American Thoracic Society (ATS) 2024 International Conference...May 12-22 in San Diego.
Earnings call: Pulmonx sees 30% sales boost in Q1, eyes $84M annual target By Investing.com
Investing.com· 13 hours agoPulmonx Corporation (ticker: LUNG) reported a robust start to 2024 with a 30% increase in worldwide...
Small Business - Cordele Dispatch | Cordele Dispatch
Cordele Dispatch· 17 hours agoPDUFA Target Action Date of June 26, 2024 Eight posters including two oral presentations support potential of ensifentrine,an investigational, first-in-class, selective, dual inhibitor of PDE3 and PDE4 LONDON and RALEIGH, N.C., May 02, 2024
Q1 2024 Pulmonx Corp Earnings Call
Thomson Reuters StreetEvents via Yahoo Finance· 13 hours agoWith that said, I'd like to pivot back to our first quarter performance...
3 Biotech Stocks to Buy and Hold Through 2030 and Beyond
Motley Fool via Yahoo Finance· 12 hours agoThe new approval grants patients the luxury of fewer injections per year without sacrificing...
Regeneron Pharmaceuticals Inc (REGN) Q1 2024 Earnings: Challenges and Opportunities Amidst ...
GuruFocus.com via Yahoo Finance· 11 hours agoRegeneron continues to advance its pipeline with several potential regulatory approvals on the...
Heart doctor relocates office in Pflugerville
Community Impact· 19 hours agoThe Cardiovascular Specialists of Texas office in Pflugerville, where Dr. Jerry Gilbert practices, has relocated to a new location in the Stone Hill Town...
MannKind advances new inhaled NTM lung disease treatment By Investing.com
Investing.com· 4 days agoMannKind (NASDAQ:MNKD) Corporation (NASDAQ:MNKD), a biopharmaceutical company, announced today the...
